Diabetic Microvascular Disease: An Endocrine Society Scientific Statement

Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs. Our understanding of the genesis of this injury and of potential interventions to prevent, limit, or reverse injury/dysfunction is continuously evolving. This statement reviews biochemical/cellular pathways involved in facilitating and abrogating microvascular injury. The statement summarizes the types of injury/dysfunction that occur in the three classical diabetes microvascular target tissues, the eye, the kidney, and the peripheral nervous system; the statement also reviews information on the effects of diabetes and insulin resistance on the microvasculature of skin, brain, adipose tissue, and cardiac and skeletal muscle. Despite extensive and intensive research, it is disappointing that microvascular complications of diabetes continue to compromise the quantity and quality of life for patients with diabetes. Hopefully, by understanding and building on current research findings, we will discover new approaches for prevention and treatment that will be effective for future generations.

[1]  Fitriani Fitriani,et al.  THE PREVALENCE OF DIABETIC RETINOPATHY , 2018 .

[2]  A. Izenberg,et al.  Diabetic Neuropathies , 2015, Seminars in Neurology.

[3]  P. Arner,et al.  Fatty Acids, Obesity and Insulin Resistance , 2015, Obesity Facts.

[4]  C. Sudlow,et al.  Enlarged perivascular spaces and cerebral small vessel disease , 2013, International journal of stroke : official journal of the International Stroke Society.

[5]  I. Akgun Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis , 2015 .

[6]  S. Kritchevsky,et al.  Sensory and Motor Peripheral Nerve Function and Incident Mobility Disability , 2014, Journal of the American Geriatrics Society.

[7]  David C. Anderson,et al.  Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[8]  T. Motawi,et al.  Alterations in circulating angiogenic and anti‐angiogenic factors in type 2 diabetic patients with neuropathy , 2014, Cell biochemistry and function.

[9]  J. Kielstein,et al.  Glucose levels and risk of dementia. , 2013, The New England journal of medicine.

[10]  B. Bravenboer,et al.  Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms. , 2013, European journal of pharmacology.

[11]  Larson J. Hogstrom,et al.  The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. , 2013, Cerebral cortex.

[12]  Ling Xia,et al.  Inhibition of Src Kinase Blocks High Glucose–Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice , 2013, Diabetes.

[13]  C. DeCarli,et al.  Amylin deposition in the brain: A second amyloid in Alzheimer disease? , 2013, Annals of Neurology.

[14]  L. Ferrucci,et al.  Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging , 2013, Neurobiology of Aging.

[15]  W. Mali,et al.  Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study , 2013, Journal of the Neurological Sciences.

[16]  R. Sacco,et al.  Perivascular Spaces Are Associated with Atherosclerosis: An Insight from the Northern Manhattan Study , 2013, American Journal of Neuroradiology.

[17]  L. Ferrucci,et al.  Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. , 2013, JAMA neurology.

[18]  H. Abboud,et al.  The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. , 2013, American journal of physiology. Renal physiology.

[19]  E. Schuchman,et al.  Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy , 2013, Cell and Tissue Research.

[20]  Xin Lv,et al.  CHOP/ORP150 Ratio in Endoplasmic Reticulum Stress: A New Mechanism for Diabetic Peripheral Neuropathy , 2013, Cellular Physiology and Biochemistry.

[21]  C. Annweiler,et al.  Blood pressure levels and brain volume reduction: a systematic review and meta-analysis , 2013, Journal of hypertension.

[22]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[23]  J. Muller-Delp The Coronary Microcirculation in Health and Disease , 2013 .

[24]  Á. Valverde,et al.  Insulin directly stimulates VEGF-A production in the glomerular podocyte. , 2013, American journal of physiology. Renal physiology.

[25]  G. Sobue,et al.  Association of Chronic Kidney Disease and Cerebral Small Vessel Disease with Cognitive Impairment in Elderly Patients with Type 2 Diabetes , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[26]  Aifeng Zhang,et al.  White Matter Tract Integrity of Anterior Limb of Internal Capsule in Major Depression and Type 2 Diabetes , 2013, Neuropsychopharmacology.

[27]  M. White,et al.  Serine Phosphorylation Sites on IRS2 Activated by Angiotensin II and Protein Kinase C To Induce Selective Insulin Resistance in Endothelial Cells , 2013, Molecular and Cellular Biology.

[28]  Benjamin J. Keller,et al.  From Single Nucleotide Polymorphism to Transcriptional Mechanism , 2013, Diabetes.

[29]  Yun Shi,et al.  Elevated Protein Carbonylation, and Misfolding in Sciatic Nerve from db/db and Sod1−/− Mice: Plausible Link between Oxidative Stress and Demyelination , 2013, PloS one.

[30]  M. Weiner,et al.  White matter hyperintensities: use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors. , 2013, Radiology.

[31]  W. Sheu,et al.  Advanced glycation end product Nε‐carboxymethyllysine induces endothelial cell injury: the involvement of SHP‐1‐regulated VEGFR‐2 dephosphorylation , 2013, The Journal of pathology.

[32]  Wiro J Niessen,et al.  High Blood Pressure and Cerebral White Matter Lesion Progression in the General Population , 2013, Hypertension.

[33]  A. Vinik,et al.  Neurovascular Function and Sudorimetry in Health and Disease , 2013, Current Diabetes Reports.

[34]  E. Feener,et al.  Role of plasma kallikrein in diabetes and metabolism , 2013, Thrombosis and Haemostasis.

[35]  A. Ghosh,et al.  Molecular basis of organ fibrosis: Potential therapeutic approaches , 2013, Experimental biology and medicine.

[36]  G. Alexander,et al.  Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions , 2013, Neurology.

[37]  H. Liao,et al.  VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. , 2013, Gene.

[38]  C. Jack,et al.  Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly , 2013, Neurobiology of Aging.

[39]  Y. You,et al.  Role of Nox2 in diabetic kidney disease. , 2013, American journal of physiology. Renal physiology.

[40]  S. Rich,et al.  Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy , 2013, PloS one.

[41]  Peter R Luijten,et al.  In Vivo Detection of Cerebral Cortical Microinfarcts with High-Resolution 7T MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  J. McMurray,et al.  Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) , 2013, American Journal of Nephrology.

[43]  Benjamin J. Keller,et al.  From SNP to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy , 2013 .

[44]  K. Maddipati,et al.  12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase , 2013, PloS one.

[45]  Kristine Yaffe,et al.  Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older Adults , 2013, Diabetes Care.

[46]  O. Abe,et al.  White Matter Alteration in Metabolic Syndrome , 2013, Diabetes Care.

[47]  T. Hansen,et al.  What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications? , 2013, PloS one.

[48]  J. Rosenstock,et al.  Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. , 2013, The American journal of medicine.

[49]  L. Schmetterer,et al.  Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. , 2013, Investigative ophthalmology & visual science.

[50]  D. Wasserman,et al.  Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance , 2013, Diabetes.

[51]  Sterling C. Johnson,et al.  Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults , 2013, Diabetes Care.

[52]  Lina Zhao,et al.  Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. , 2013, American journal of physiology. Endocrinology and metabolism.

[53]  G. King,et al.  Vascular complications of diabetes: mechanisms of injury and protective factors. , 2013, Cell metabolism.

[54]  H. Arai,et al.  Brain accumulation of amyloid β protein visualized by positron emission tomography and BF‐227 in Alzheimer's disease patients with or without diabetes mellitus , 2013, Geriatrics & gerontology international.

[55]  N. Vaziri,et al.  Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease , 2012, Kidney international.

[56]  S. Craft,et al.  Insulin and Alzheimer's disease: untangling the web. , 2012, Journal of Alzheimer's disease : JAD.

[57]  B. Astor,et al.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.

[58]  Sam K. Y. Sim,et al.  Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[59]  Benjamin J. Keller,et al.  A Model for FRMD3 in Diabetic Nephropathy , 2013 .

[60]  G. Pandini,et al.  Insulin has multiple antiamyloidogenic effects on human neuronal cells. , 2013, Endocrinology.

[61]  K. Skorecki,et al.  Hypertension-misattributed kidney disease in African Americans. , 2013, Kidney international.

[62]  A. Vinik,et al.  Diabetic neuropathy. , 2013, Endocrinology and metabolism clinics of North America.

[63]  M. Mishra,et al.  Factor Nrf 2-Mediated Antioxidant Defense System in the Development of Diabetic Retinopathy , 2013 .

[64]  Y. You,et al.  Chronic Kidney Disease and Fibrosis Role of Nox 2 in diabetic kidney disease , 2013 .

[65]  H. Yip,et al.  Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease , 2013, Clinical and Experimental Nephrology.

[66]  E. Barrett,et al.  The endothelial cell: An “early responder” in the development of insulin resistance , 2013, Reviews in Endocrine and Metabolic Disorders.

[67]  A. Leemans,et al.  Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes , 2012, Diabetes Care.

[68]  E. Barrett,et al.  Early Microvascular Recruitment Modulates Subsequent Insulin-Mediated Skeletal Muscle Glucose Metabolism During Lipid Infusion , 2012, Diabetes Care.

[69]  S. Correia,et al.  The impairment of insulin signaling in Alzheimer's disease , 2012, IUBMB life.

[70]  B. Dormanesh,et al.  Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[71]  A. Hofman,et al.  Determinants of cerebellar and cerebral volume in the general elderly population , 2012, Neurobiology of Aging.

[72]  J. Murabito,et al.  Prevalence, Distribution, and Risk Factor Correlates of High Thoracic Periaortic Fat in the Framingham Heart Study , 2012, Journal of the American Heart Association.

[73]  R. Akinyemi,et al.  Does vascular pathology contribute to Alzheimer changes? , 2012, Journal of the Neurological Sciences.

[74]  Y. Moon,et al.  An Advanced Glycation End Product (AGE)-Receptor for AGEs (RAGE) Axis Restores Adipogenic Potential of Senescent Preadipocytes through Modulation of p53 Protein Function* , 2012, The Journal of Biological Chemistry.

[75]  R. Bilous,et al.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[76]  G. Biessels,et al.  An update on type 2 diabetes, vascular dementia and Alzheimer's disease , 2012, Experimental Gerontology.

[77]  E. Kanal Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview. , 2012, Magnetic resonance imaging clinics of North America.

[78]  H. Baelde,et al.  Vegfa Protects the Glomerular Microvasculature in Diabetes , 2012, Diabetes.

[79]  Allan L. Reiss,et al.  White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study , 2012, Diabetes Care.

[80]  Yao-min Hu,et al.  A systematic review and meta-analysis of a-lipoic acid in the treatment of diabetic peripheral neuropathy , 2012 .

[81]  S. Stone-Elander,et al.  Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes , 2012, Nature.

[82]  P. Toth,et al.  The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus , 2012, Cardiovascular Diabetology.

[83]  M. Loitfelder,et al.  Cerebral microbleeds: a review. , 2012, Panminerva medica.

[84]  R. Gabbay,et al.  Comparison of retinal vasodilator and constrictor responses in type 2 diabetes , 2012, Acta ophthalmologica.

[85]  Benjamin J. Keller,et al.  New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes , 2012, PLoS genetics.

[86]  E. Newman,et al.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease , 2012, Progress in Retinal and Eye Research.

[87]  Sookja K. Chung,et al.  Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. , 2012, Investigative ophthalmology & visual science.

[88]  M. Shenton,et al.  Resting-State Brain Functional Connectivity Is Altered in Type 2 Diabetes , 2012, Diabetes.

[89]  R. Kahn,et al.  Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies , 2012, Human brain mapping.

[90]  A. Convit,et al.  Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal atrophy , 2012, Psychoneuroendocrinology.

[91]  Evan Fletcher,et al.  Coevolution of white matter hyperintensities and cognition in the elderly , 2012, Neurology.

[92]  D. Agalliu,et al.  The role of pericytes in blood-brain barrier function and stroke. , 2012, Current pharmaceutical design.

[93]  J. Hirschhorn,et al.  Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy , 2012, Diabetes.

[94]  A. Paterson,et al.  Does Familial Clustering of Risk Factors for Long-Term Diabetic Complications Leave Any Place for Genes That Act independently? , 2012, Journal of Cardiovascular Translational Research.

[95]  B. Frier,et al.  Diabetes and cognitive dysfunction , 2012, The Lancet.

[96]  S. Tafuro,et al.  Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced Obesity and Insulin Resistance , 2012, Diabetes.

[97]  K. Kalantar-Zadeh A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.

[98]  B. Freedman A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.

[99]  Ronald Klein,et al.  Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. , 2012, Archives of ophthalmology.

[100]  L. Ferrucci,et al.  Baseline Cardiovascular Risk Predicts Subsequent Changes in Resting Brain Function , 2012, Stroke.

[101]  P. Liu,et al.  Resistance to obesity by repression of VEGF gene expression through induction of brown-like adipocyte differentiation. , 2012, Endocrinology.

[102]  D. Antonetti,et al.  Protein Kinase Cβ Phosphorylates Occludin Regulating Tight Junction Trafficking in Vascular Endothelial Growth Factor–Induced Permeability In Vivo , 2012, Diabetes.

[103]  K. Griendling,et al.  Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System , 2012, Circulation research.

[104]  C. Huang,et al.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies , 2012, Internal medicine journal.

[105]  Y. Reijmer,et al.  Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes. , 2012, Journal of diabetes and its complications.

[106]  J. Skupień,et al.  The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.

[107]  S. Studenski,et al.  Vitamin B12 and Neurological Function: Is There a Threshold Level? (P02.059) , 2012 .

[108]  G. King,et al.  Glomerular VEGF resistance induced by PKCδ/SHP‐1 activation and contribution to diabetic nephropathy , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  H. Verhaar,et al.  association of chronic kidney disease with brain lesions on MRI or CT : systematic review , 2012 .

[110]  P. Sirois,et al.  Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954 , 2012, Peptides.

[111]  C. Langefeld,et al.  Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[112]  E. Vaucher,et al.  Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats , 2012, PloS one.

[113]  L. Tao,et al.  Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide–Dependent Mechanism , 2012, Diabetes.

[114]  R. DePinho,et al.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. , 2012, Cell metabolism.

[115]  Paula I. Moreira,et al.  Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation , 2012, Brain Research.

[116]  L. Kappelle,et al.  Diabetes, hyperglycaemia, and acute ischaemic stroke , 2012, The Lancet Neurology.

[117]  Deyu Zhao,et al.  Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects , 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[118]  Eric E. Smith,et al.  Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.

[119]  K. Kalantar-Zadeh,et al.  Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes , 2012, Diabetes.

[120]  Samantha J. Brooks,et al.  Impaired Insulin Sensitivity as Indexed by the HOMA Score Is Associated With Deficits in Verbal Fluency and Temporal Lobe Gray Matter Volume in the Elderly , 2012, Diabetes Care.

[121]  E. Maltezos,et al.  α-Lipoic Acid, Diabetic Neuropathy, and Nathan’s Prophecy , 2012, Angiology.

[122]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[123]  Avi Ma'ayan,et al.  Systems approach identifies HIPK2 as a critical regulator of kidney fibrosis , 2012, Nature Medicine.

[124]  Jung-Lung Hsu,et al.  Microstructural white matter abnormalities in type 2 diabetes mellitus: A diffusion tensor imaging study , 2012, NeuroImage.

[125]  M. Szklo,et al.  Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study , 2012, Neurology.

[126]  D. Poulikakos,et al.  Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo , 2012, Nature Communications.

[127]  J. Wang,et al.  ER Stress and Apoptosis: A New Mechanism for Retinal Cell Death , 2011, Experimental diabetes research.

[128]  Usrds NIH, U. . Renal Data System: Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. , 2012 .

[129]  W. Cefalu A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: AM atter of Life or Death Time to dispense with the hemoglobin A1C in end-stage kidney , 2012 .

[130]  Ning Wang,et al.  Treatment effects of captopril on non-proliferative diabetic retinopathy. , 2012, Chinese medical journal.

[131]  F. Ismail-Beigi,et al.  Clinical implications of the ACCORD trial. , 2012, The Journal of clinical endocrinology and metabolism.

[132]  T. Han,et al.  A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy , 2012 .

[133]  Peter Riederer,et al.  Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways , 2012, Journal of Neural Transmission.

[134]  E. Uzar,et al.  Serum prolidase activity and oxidative status in patients with diabetic neuropathy , 2012, Neurological Sciences.

[135]  B. Kovatchev,et al.  Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus , 2012, Diabetologia.

[136]  Mark E Molitch,et al.  Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. , 2011, The New England journal of medicine.

[137]  M. White,et al.  Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)* , 2011, The Journal of Biological Chemistry.

[138]  T. Kern,et al.  Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia , 2011, Molecular vision.

[139]  Lippincott Williams Wilkins,et al.  Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination , 2011, Neurology.

[140]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[141]  J. Bülow,et al.  The dynamics of the microcirculation in the subcutaneous adipose tissue is impaired in the postprandial state in type 2 diabetes , 2011, Clinical physiology and functional imaging.

[142]  A. Ashley-Koch,et al.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy , 2011, British journal of haematology.

[143]  A. Reiss,et al.  Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease , 2011, Neurobiology of Aging.

[144]  V. Bautch,et al.  Stem cells and the vasculature , 2011, Nature Medicine.

[145]  R. Kowluru,et al.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease? , 2011, Investigative ophthalmology & visual science.

[146]  Christos Davatzikos,et al.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy , 2011, The Lancet Neurology.

[147]  Giulio Genovese,et al.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[148]  P. Westermark,et al.  Localized amyloids important in diseases outside the brain – lessons from the islets of Langerhans and the thoracic aorta , 2011, The FEBS journal.

[149]  C. DeCarli,et al.  Vitamin B12, cognition, and brain MRI measures , 2011, Neurology.

[150]  E. Barrett,et al.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. , 2011, American journal of physiology. Endocrinology and metabolism.

[151]  H. Hammes,et al.  Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema , 2011, Ophthalmologica.

[152]  R. Freeman,et al.  Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy , 2011, Diabetes Care.

[153]  B. Zinman,et al.  Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control , 2011, Diabetes Care.

[154]  Sudha Seshadri,et al.  Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults , 2011, Diabetes Care.

[155]  J. L. Wilkinson‐Berka,et al.  Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat , 2011, Diabetologia.

[156]  A. Vinik,et al.  Neuropathy in prediabetes: does the clock start ticking early? , 2011, Nature Reviews Endocrinology.

[157]  K. Clément,et al.  Increased Adipose Tissue Oxygen Tension in Obese Compared With Lean Men Is Accompanied by Insulin Resistance, Impaired Adipose Tissue Capillarization, and Inflammation , 2011, Circulation.

[158]  M. Sporn,et al.  Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. , 2011, Free radical biology & medicine.

[159]  M. Brundel,et al.  Cerebral microinfarcts: A systematic review of neuropathological studies , 2011, Alzheimer's & Dementia.

[160]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[161]  E. Barrett,et al.  Salsalate Attenuates Free Fatty Acid–Induced Microvascular and Metabolic Insulin Resistance in Humans , 2011, Diabetes Care.

[162]  T. Dalkara,et al.  Brain microvascular pericytes in health and disease , 2011, Acta Neuropathologica.

[163]  M. Landray,et al.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.

[164]  R. Morishita,et al.  Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. , 2011, Molecular bioSystems.

[165]  A. Vinik,et al.  Autonomic imbalance: prophet of doom or scope for hope? , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[166]  T. Ahluwalia,et al.  Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes , 2011, Diabetologia.

[167]  Catherine Egan,et al.  SDOCT Imaging to Identify Macular Pathology in Patients Diagnosed with Diabetic Maculopathy by a Digital Photographic Retinal Screening Programme , 2011, PloS one.

[168]  C. DeCarli,et al.  Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). , 2011, Atherosclerosis.

[169]  A. Vinik,et al.  Quality of Life and Objective Measures of Diabetic Neuropathy in a Prospective Placebo-Controlled Trial of Ruboxistaurin and Topiramate , 2011, Journal of diabetes science and technology.

[170]  D. Kolte,et al.  Biochemical characterization of a novel high‐affinity and specific plasma kallikrein inhibitor , 2011, British journal of pharmacology.

[171]  A. Clermont,et al.  Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats , 2011, Diabetes.

[172]  Jennifer K. Sun,et al.  Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration , 2011, Diabetes Care.

[173]  B. Zinman,et al.  Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. , 2011, Archives of internal medicine.

[174]  T. Kodama,et al.  Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. , 2011, Cell metabolism.

[175]  A. Hofman,et al.  Incidence of Cerebral Microbleeds in the General Population: The Rotterdam Scan Study , 2011, Stroke.

[176]  Jasmin Divers,et al.  A genome-wide association study for diabetic nephropathy genes in African Americans. , 2011, Kidney international.

[177]  G. R. Jackson,et al.  An integrated approach to diabetic retinopathy research. , 2011, Archives of ophthalmology.

[178]  M. Rocco,et al.  Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. , 2011, Human pathology.

[179]  M. Strachan R D Lawrence Lecture 2010 ^ . The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[180]  E. Barrett,et al.  Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. , 2011, The Journal of clinical endocrinology and metabolism.

[181]  Riccardo E. Marioni,et al.  Cognitive function, dementia and type 2 diabetes mellitus in the elderly , 2011, Nature Reviews Endocrinology.

[182]  P. Carmeliet,et al.  Neuronal FLT1 receptor and its selective ligand VEGF‐B protect against retrograde degeneration of sensory neurons , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[183]  D. Wasserman,et al.  The physiological regulation of glucose flux into muscle in vivo , 2011, Journal of Experimental Biology.

[184]  S. Minoshima,et al.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.

[185]  C. Sapienza,et al.  DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy , 2011, Epigenetics.

[186]  T. Skalak,et al.  Hemodynamic Systems Analysis of Capillary Network Remodeling During the Progression of Type 2 Diabetes , 2011, Microcirculation.

[187]  R. Minshall,et al.  A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase , 2009, Journal of cellular and molecular medicine.

[188]  S. Antonio Genomewide Linkage Scan for Diabetic Renal Failure and Albuminuria: The FIND Study , 2011 .

[189]  H. Velázquez,et al.  Podocyte vascular endothelial growth factor (Vegf164) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes , 2011, Diabetologia.

[190]  Jeroen de Bresser,et al.  Cerebral cortical thickness in patients with type 2 diabetes , 2010, Journal of the Neurological Sciences.

[191]  V. Gudnason,et al.  Cerebral microbleeds, retinopathy, and dementia , 2010, Neurology.

[192]  O. Dekkers,et al.  Genetic associations in diabetic nephropathy: a meta-analysis , 2010, Diabetologia.

[193]  R. Hanson,et al.  ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. , 2010, Molecular genetics and metabolism.

[194]  B. Freedman,et al.  Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[195]  C. Langefeld,et al.  The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[196]  Owen Carmichael,et al.  Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. , 2010, Archives of neurology.

[197]  J. Coombes,et al.  Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. , 2010, Atherosclerosis.

[198]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[199]  C. Forsblom,et al.  Genetic Polymorphisms in Nitric Oxide Synthase 3 Gene and Implications for Kidney Disease: A Meta-Analysis , 2010, American Journal of Nephrology.

[200]  C. Kahn,et al.  Insulin signaling to the glomerular podocyte is critical for normal kidney function. , 2010, Cell metabolism.

[201]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[202]  Aad van der Lugt,et al.  Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study , 2010, Stroke.

[203]  Bryan Maloney,et al.  Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications , 2010, Experimental Neurology.

[204]  L. Ferrucci,et al.  Does accumulation of advanced glycation end products contribute to the aging phenotype? , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[205]  C. Winkler,et al.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. , 2010, Journal of the American Society of Nephrology : JASN.

[206]  A. Dale,et al.  Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. , 2010, Cerebral cortex.

[207]  Xilin Yang,et al.  Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. , 2010, JAMA.

[208]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[209]  Ann L. Albright,et al.  Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.

[210]  Rodica Pop-Busui,et al.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.

[211]  R. Klein,et al.  Are Individuals With Diabetes Seeing Better? , 2010, Diabetes.

[212]  C. Enzinger,et al.  The Impact of Sex and Vascular Risk Factors on Brain Tissue Changes with Aging: Magnetization Transfer Imaging Results of the Austrian Stroke Prevention Study , 2010, American Journal of Neuroradiology.

[213]  R. G. Miller,et al.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.

[214]  Walter T Ambrosius,et al.  Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.

[215]  S. Chung,et al.  More severe type 2 diabetes‐associated ischemic stroke injury is alleviated in aldose reductase‐deficient mice , 2010, Journal of neuroscience research.

[216]  J. Valls-Solé,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society , 2010, European journal of neurology.

[217]  A. Vinik,et al.  Neuropathy: The Crystal Ball for Cardiovascular Disease? , 2010, Diabetes Care.

[218]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[219]  C. Fox,et al.  Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. , 2010, Atherosclerosis.

[220]  Lloyd Paul Aiello,et al.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010, Ophthalmology.

[221]  R. Ramasamy,et al.  Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. , 2010, Biochemical pharmacology.

[222]  Robia G. Pautler,et al.  Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.

[223]  J. Sahel,et al.  Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. , 2010, Current opinion in investigational drugs.

[224]  R. Klein,et al.  Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. , 2010, American journal of ophthalmology.

[225]  S. Garg,et al.  Complications of intravitreal injections , 2010, Current opinion in ophthalmology.

[226]  A. Yoshida,et al.  Acute hyperglycemia-induced endothelial dysfunction in retinal arterioles in cats. , 2010, Investigative ophthalmology & visual science.

[227]  G. King,et al.  Activation of protein kinase C isoforms and its impact on diabetic complications. , 2010, Circulation research.

[228]  M. Grant,et al.  Erratum: The promise of cell-based therapies for diabetic complications: Challenges and solutions (Circulation Research (2010) 106 (854-869) , 2010 .

[229]  R. Skidgel,et al.  Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors , 2010, Neuropeptides.

[230]  N. Powe,et al.  Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[231]  F. Dekker,et al.  Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific , 2010, Diabetes.

[232]  Z. Ni,et al.  Prevalence of non-diabetic renal disease in patients with type 2 diabetes. , 2010, Diabetes research and clinical practice.

[233]  S. Li Calzi,et al.  Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits , 2010, EPMA Journal.

[234]  A. Kazlauskas,et al.  Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. , 2010, Experimental eye research.

[235]  Karen J. Ferguson,et al.  Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.

[236]  J. Albers,et al.  Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study , 2010, Diabetes Care.

[237]  Jianguo Zhang,et al.  Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. , 2010, Omics : a journal of integrative biology.

[238]  T. Hansen,et al.  A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 Diabetes , 2010, PLoS genetics.

[239]  N. Durany,et al.  Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus , 2010, Neurobiology of Disease.

[240]  S. Woods,et al.  Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight , 2010, Diabetes.

[241]  Activated protein C protects against diabetic nephropathy , 2010 .

[242]  H. Hara,et al.  Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. , 2010, Experimental eye research.

[243]  A. Attie,et al.  Secretion and Peripheral Insulin Action The Role of Blood Vessels, Endothelial Cells, and Vascular Pericytes in Insulin , 2010 .

[244]  G. Siuzdak,et al.  Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy , 2010, Glia.

[245]  E. Świętochowska,et al.  Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy , 2010, Clinical and Experimental Medicine.

[246]  M. Boulton,et al.  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock , 2009, The Journal of experimental medicine.

[247]  L. Messina,et al.  Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. , 2009, Journal of vascular surgery.

[248]  Yi Li,et al.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies , 2009, Journal of clinical neurology.

[249]  L. Aiello,et al.  Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy , 2009, Nature Medicine.

[250]  Angelo J. Canty,et al.  A Genome-Wide Association Study Identifies a Novel Major Locus for Glycemic Control in Type 1 Diabetes, as Measured by Both A1C and Glucose , 2009, Diabetes.

[251]  C. Grillo,et al.  Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent , 2009, Brain Research.

[252]  M. Woodward,et al.  Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. , 2009, Archives of internal medicine.

[253]  Blair H. Smith,et al.  Assessment of neuropathic pain in primary care. , 2009, The American journal of medicine.

[254]  E. Barrett,et al.  The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production. , 2009, Molecular endocrinology.

[255]  C. Langefeld,et al.  Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping , 2009, Human Genetics.

[256]  E. Barrett,et al.  Muscle Contraction, but Not Insulin, Increases Microvascular Blood Volume in the Presence of Free Fatty Acid–Induced Insulin Resistance , 2009, Diabetes.

[257]  Stephen S. Rich,et al.  Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy , 2009, Diabetes.

[258]  M. Saito,et al.  Role of cyclooxygenase in vasodilation of retinal blood vessels induced by bradykinin in Brown Norway rats. , 2009, Vascular pharmacology.

[259]  A. Toga,et al.  Brain Structure and Obesity , 2009, NeuroImage.

[260]  J. Albers,et al.  Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.

[261]  E. Barrett,et al.  Obesity Blunts Microvascular Recruitment in Human Forearm Muscle After a Mixed Meal , 2009, Diabetes Care.

[262]  A. Krolewski,et al.  Early nephropathy in type 1 diabetes: the importance of early renal function decline , 2009, Current opinion in nephrology and hypertension.

[263]  Merlin C. Thomas,et al.  The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.

[264]  Donald W. Bowden,et al.  The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans , 2009, Human Genetics.

[265]  J. Ochoa,et al.  NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.

[266]  Yongmei Liu,et al.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. , 2009, Kidney international.

[267]  Hong Wang,et al.  The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action , 2009, Diabetologia.

[268]  C. Langefeld,et al.  Variants in Intron 13 of the ELMO1 Gene are Associated with Diabetic Nephropathy in African Americans , 2009, Annals of human genetics.

[269]  Judy E. Kim,et al.  Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. , 2009, Archives of ophthalmology.

[270]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[271]  J. Rood,et al.  Reduced Adipose Tissue Oxygenation in Human Obesity , 2009, Diabetes.

[272]  Stephen S. Rich,et al.  Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes , 2009, Diabetes.

[273]  J. Weinberg,et al.  Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes , 2009, Diabetes Care.

[274]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[275]  T. Suuronen,et al.  Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors , 2009, Progress in Neurobiology.

[276]  S. Bursell,et al.  Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability , 2009, Hypertension.

[277]  B. Grinnell,et al.  Distinct functions of activated protein C differentially attenuate acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.

[278]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[279]  Sarah Aldred,et al.  Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. , 2008, Journal of Alzheimer's disease : JAD.

[280]  R. King,et al.  Epineurial microvasculitis in proximal diabetic neuropathy , 1998, Journal of Neurology.

[281]  Z. Milicevic,et al.  Anti-ganglioside GM1 antibody and distal symmetric “diabetic polyneuropathy” with dominant motor features , 1997, Diabetologia.

[282]  J. Luchsinger,et al.  Adiposity, type 2 diabetes, and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[283]  J. Tamsma,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[284]  W. Elliott Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease , 2009 .

[285]  R. Garrick Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2009 .

[286]  Ge Li,et al.  Neuropathology in the adult changes in thought study: a review. , 2009, Journal of Alzheimer's disease : JAD.

[287]  R. Klein,et al.  The Role of Genetics in Susceptibility to Diabetic Retinopathy , 2009, International ophthalmology clinics.

[288]  G. Perry,et al.  Involvement of maillard reactions in Alzheimer disease , 2009, Neurotoxicity Research.

[289]  F. Ziyadeh,et al.  Vascular endothelial growth factor and diabetic nephropathy , 2008, Current diabetes reports.

[290]  B. Mueller,et al.  Diffusion Tensor Imaging Identifies Deficits in White Matter Microstructure in Subjects With Type 1 Diabetes That Correlate With Reduced Neurocognitive Function , 2008, Diabetes.

[291]  A. Vinik,et al.  German-Translated Norfolk Quality of Life (QOL-DN) Identifies the Same Factors as the English Version of the Tool and Discriminates Different Levels of Neuropathy Severity , 2008, Journal of diabetes science and technology.

[292]  A. Smith,et al.  Plasma vitamin B12 status and cerebral white-matter lesions , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[293]  R. Klein,et al.  Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.

[294]  H. Parving,et al.  Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.

[295]  Rury R Holman,et al.  Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.

[296]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[297]  T. Nyström,et al.  The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[298]  K. Wanic,et al.  Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes , 2008, Diabetes.

[299]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.

[300]  S. Yusuf,et al.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial , 2008, The Lancet.

[301]  J. Abraham,et al.  Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats , 2008, Metabolic Brain Disease.

[302]  K. Yaffe,et al.  Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2009 .

[303]  S. Madsen-Bouterse,et al.  Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives , 2008, Reviews in Endocrine and Metabolic Disorders.

[304]  H. D. Vanguilder,et al.  Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina , 2008, The European journal of neuroscience.

[305]  R. Bache,et al.  Regulation of coronary blood flow during exercise. , 2008, Physiological reviews.

[306]  C. Fox,et al.  Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988–1994 to 1999–2004 , 2008, Diabetes Care.

[307]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[308]  Vilmundur Gudnason,et al.  Retinal and Cerebral Microvascular Signs and Diabetes , 2008, Diabetes.

[309]  Allen R Kunselman,et al.  Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.

[310]  J. Hendrikse,et al.  Cerebral perfusion in relation to cognitive function and type 2 diabetes , 2008, Diabetologia.

[311]  J. Becker,et al.  Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study , 2008, Neurology.

[312]  D. Ziegler Painful diabetic neuropathy: treatment and future aspects , 2008, Diabetes/metabolism research and reviews.

[313]  S. Talbot,et al.  Retinal plasma extravasation in streptozotocin‐diabetic rats mediated by kinin B1 and B2 receptors , 2008, British journal of pharmacology.

[314]  B. Freedman,et al.  Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.

[315]  Charles E. Riva,et al.  Regulation of retinal blood flow in health and disease , 2008, Progress in Retinal and Eye Research.

[316]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[317]  K. Kamata,et al.  Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. , 2008, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[318]  M. V. Dinther,et al.  Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. , 2008, Kidney international.

[319]  S. Kaushal,et al.  Intravitreal steroids for macular edema: the past, the present, and the future. , 2008, Survey of ophthalmology.

[320]  S. Weisberg,et al.  Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration , 2008, International Journal of Obesity.

[321]  O. Lopez,et al.  Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[322]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[323]  M. Cooper,et al.  Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway , 2008, Diabetes.

[324]  H. Okamoto,et al.  Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. , 2008, International immunopharmacology.

[325]  R. Elston,et al.  Genome-Wide Scan for Estimated Glomerular Filtration Rate in Multi-Ethnic Diabetic Populations , 2008, Diabetes.

[326]  Olusola Ajilore,et al.  Gray matter prefrontal changes in type 2 diabetes detected using MRI , 2008, Journal of magnetic resonance imaging : JMRI.

[327]  H. Parving,et al.  DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. , 2008 .

[328]  R. Kunz,et al.  Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the ReninAngiotensin System on Proteinuria in Renal Disease , 2008, Annals of Internal Medicine.

[329]  A. Sadosky,et al.  A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain Conditions , 2008, Pain practice : the official journal of World Institute of Pain.

[330]  M. Mintun,et al.  Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. , 2008, Archives of neurology.

[331]  Filippo Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[332]  E. Barrett,et al.  Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. , 2007, American journal of physiology. Endocrinology and metabolism.

[333]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[334]  D. Selkoe,et al.  Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway* , 2007, Journal of Biological Chemistry.

[335]  M. Esiri,et al.  Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia , 2007, BMC neurology.

[336]  Raghu Kalluri,et al.  Structure and Function of Basement Membranes , 2007, Experimental biology and medicine.

[337]  Jianping Ye,et al.  Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[338]  A. Algra,et al.  Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes , 2007, Diabetologia.

[339]  E. Barrett,et al.  Contraction Stimulates Nitric Oxide–Independent Microvascular Recruitment and Increases Muscle Insulin Uptake , 2007, Diabetes.

[340]  S. Soltoff,et al.  Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. , 2007, Trends in pharmacological sciences.

[341]  Zhenqi Liu Insulin at physiological concentrations increases microvascular perfusion in human myocardium. , 2007, American journal of physiology. Endocrinology and metabolism.

[342]  J. Wardlaw,et al.  Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. , 2007, Brain : a journal of neurology.

[343]  M. Artwohl,et al.  Insulin does not regulate glucose transport and metabolism in human endothelium , 2007, European journal of clinical investigation.

[344]  Jennifer K. Sun,et al.  Clinical Factors Associated With Resistance to Microvascular Complications in Diabetic Patients of Extreme Disease Duration , 2007, Diabetes Care.

[345]  L. Papa,et al.  The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells , 2007, Molecular and Cellular Biochemistry.

[346]  C. Stehouwer,et al.  Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. , 2007, Hypertension.

[347]  R. Colman,et al.  Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology , 2007, Thrombosis and Haemostasis.

[348]  R. Elston,et al.  Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations , 2007, Diabetes.

[349]  M. A. Viergever,et al.  Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus , 2007, Diabetologia.

[350]  H. O. Neto,et al.  Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy , 2007 .

[351]  I. Liu,et al.  Prevalence of Nondiabetic Renal Disease in Diabetic Patients , 2007, American Journal of Nephrology.

[352]  B. Freedman,et al.  Familial Clustering of Chronic Kidney Disease , 2007, Seminars in dialysis.

[353]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[354]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.

[355]  J. Weinberg,et al.  Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. , 2007, Journal of the American Society of Nephrology : JASN.

[356]  H. Haller,et al.  Deletion of Protein Kinase C-ε Signaling Pathway Induces Glomerulosclerosis and Tubulointerstitial Fibrosis In Vivo , 2007 .

[357]  E. Boerwinkle,et al.  A Genome-Wide Linkage Scan for Diabetic Retinopathy Susceptibility Genes in Mexican Americans With Type 2 Diabetes From Starr County, Texas , 2007, Diabetes.

[358]  C. Langefeld,et al.  A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[359]  John V Pearson,et al.  Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study , 2007, Diabetes.

[360]  P. Galuppo,et al.  Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes , 2007, Diabetes.

[361]  M. Inaba,et al.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. , 2007, Journal of the American Society of Nephrology : JASN.

[362]  F Fazekas,et al.  Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[363]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[364]  S. Calafato,et al.  Oxidative stress and cellular stress response in diabetic nephropathy , 2007, Cell stress & chaperones.

[365]  H. Haller,et al.  Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. , 2007, Journal of the American Society of Nephrology : JASN.

[366]  P. Scheltens,et al.  Brain Lesions on MRI in Elderly Patients with Type 2 Diabetes Mellitus , 2006, European Neurology.

[367]  Jonathan Stone,et al.  Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages , 2006, Neurobiology of Aging.

[368]  G. King,et al.  Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ–Null Mice , 2006, Diabetes.

[369]  Geert Jan Biessels,et al.  Brain Imaging in Patients With Diabetes , 2006, Diabetes Care.

[370]  U. Munzel,et al.  Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.

[371]  J. Pacella,et al.  Effect of Coronary Stenosis on Adjacent Bed Flow Reserve: Assessment of Microvascular Mechanisms Using Myocardial Contrast Echocardiography , 2006, Circulation.

[372]  K. Chow,et al.  Risk factors of vitamin B(12) deficiency in patients receiving metformin. , 2006, Archives of internal medicine.

[373]  L. Aiello,et al.  Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. , 2006, Ophthalmology.

[374]  Jean-Luc Cracowski,et al.  Methodological issues in the assessment of skin microvascular endothelial function in humans. , 2006, Trends in pharmacological sciences.

[375]  S. Groeschel,et al.  Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature , 2006, Neuroradiology.

[376]  R. Kawamori,et al.  Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy , 2006, Diabetes Care.

[377]  S. Chung,et al.  Aldose Reductase–Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage , 2006, Diabetes.

[378]  Jonathan R Lindner,et al.  Mixed meal and light exercise each recruit muscle capillaries in healthy humans. , 2006, American journal of physiology. Endocrinology and metabolism.

[379]  Ting Zhao,et al.  Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts , 2006, Journal of Pharmacology and Experimental Therapeutics.

[380]  S. Sacco,et al.  A population-based study of the incidence and prognosis of lacunar stroke , 2006, Neurology.

[381]  A. Vinik,et al.  Diabetic neuropathies: clinical manifestations and current treatment options , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[382]  E. Barrett,et al.  Obesity Blunts Insulin-Mediated Microvascular Recruitment in Human Forearm Muscle , 2006, Diabetes.

[383]  K. Isshiki,et al.  Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria. , 2006, Diabetes care.

[384]  Jeroen van der Grond,et al.  Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. , 2006, Diabetes.

[385]  M. Brownlee,et al.  Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy , 2006, Diabetologia.

[386]  A. Goldfine,et al.  Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. , 2006, Diabetes.

[387]  F. Faraci Reactive oxygen species: influence on cerebral vascular tone. , 2006, Journal of applied physiology.

[388]  Simon Vogrin,et al.  Cerebral cortex: An MRI-based study of volume and variance with age and sex , 2006, Journal of Clinical Neuroscience.

[389]  R Nick Bryan,et al.  Retinal Microvascular Abnormalities and MRI-Defined Subclinical Cerebral Infarction: The Atherosclerosis Risk in Communities Study , 2006, Stroke.

[390]  M. Burnier,et al.  Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes , 2006, Journal of hypertension.

[391]  K. Airaksinen,et al.  Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. , 2005, Diabetes.

[392]  H. Hammes,et al.  Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. , 2006, Diabetologia.

[393]  W. Burger,et al.  Risk factors for the development of retinopathy in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus , 2006, Diabetologia.

[394]  Niels D Prins,et al.  Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. , 2006, Brain : a journal of neurology.

[395]  A. Avogaro,et al.  Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. , 2006, Diabetes care.

[396]  Ann Marie Schmidt,et al.  Injury Advanced Glycation End Products : Sparking the Development of Diabetic Vascular , 2006 .

[397]  R. Buchanan,et al.  Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. , 2006, Diabetes care.

[398]  Thomas E. Lyons,et al.  Early changes in the skin microcirculation and muscle metabolism of the diabetic foot , 2005, The Lancet.

[399]  H. Schmidt,et al.  NADPH Oxidase Activity and Function Are Profoundly Greater in Cerebral Versus Systemic Arteries , 2005, Circulation research.

[400]  J. Williamson,et al.  Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies , 2005, Diabetologia.

[401]  Karen L. Price,et al.  Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy , 2005, Muscle & nerve.

[402]  J. McGill,et al.  The effect of ruboxistaurin on nephropathy in type 2 diabetes. , 2005, Diabetes care.

[403]  T. Montine,et al.  Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. , 2005, Archives of neurology.

[404]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[405]  B. Freedman,et al.  Population-Based Screening for Family History of End-Stage Renal Disease among Incident Dialysis Patients , 2005, American Journal of Nephrology.

[406]  A. Vinik,et al.  Small fiber neuropathy is associated with the metabolic syndrome. , 2005, Metabolic syndrome and related disorders.

[407]  Karen L. Price,et al.  Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. , 2005, Clinical therapeutics.

[408]  J. Frisbee Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[409]  H. Hammes,et al.  Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. , 2005, Diabetes.

[410]  A. Vinik,et al.  Antibodies to neuronal structures: innocent bystanders or neurotoxins? , 2005, Diabetes care.

[411]  M. Peakman,et al.  Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. , 2005, Diabetes care.

[412]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[413]  A. Avogaro,et al.  Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients , 2005, Circulation.

[414]  G. Chertow,et al.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.

[415]  Yuan Zhang,et al.  Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[416]  A. Vinik,et al.  The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. , 2005, Diabetes technology & therapeutics.

[417]  K. Jandeleit-Dahm,et al.  Advanced Glycation End Products in Diabetes‐Associated Atherosclerosis and Renal Disease: Interventional Studies , 2005, Annals of the New York Academy of Sciences.

[418]  W. Herman,et al.  Underdiagnosis of peripheral neuropathy in type 2 diabetes. , 2005, Diabetes care.

[419]  P. Matthews,et al.  Risk factors for progression of brain atrophy in aging , 2005, Neurology.

[420]  F. Nantel,et al.  Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs. , 2005, European journal of pharmacology.

[421]  F. Kim,et al.  Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[422]  K. Chia,et al.  Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects , 2005, Diabetologia.

[423]  J. Jonas,et al.  Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. , 2005, Ophthalmology.

[424]  A. Krolewski,et al.  Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. , 2005, Advances in chronic kidney disease.

[425]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[426]  Yusuke Nakamura,et al.  Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. , 2005, Diabetes.

[427]  P. Dyck,et al.  Diabetic Neuropathies: Classification, Clinical Features, and Pathophysiological Basis , 2005, The neurologist.

[428]  W. Köpcke,et al.  Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). , 2005, International journal of clinical pharmacology and therapeutics.

[429]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[430]  G. Gronseth,et al.  Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.

[431]  F. Gries,et al.  The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes , 1988, Klinische Wochenschrift.

[432]  Grupa badawcza Pkc-Drs The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy. Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial , 2005 .

[433]  J. S. Yudkin,et al.  "Vasocrine" signalling from perivascular , 2005 .

[434]  R. Elston,et al.  The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. , 2005, Journal of diabetes and its complications.

[435]  Jeffrey A. Cohen,et al.  Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. , 2005, Archives of physical medicine and rehabilitation.

[436]  F. Kim,et al.  Downloaded from http://atvb.ahajournals.org / by guest on February 23, 2013Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKK� , 2022 .

[437]  K. Sharma,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus , 2004, Current diabetes reports.

[438]  J. Manson,et al.  A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. , 2004, Diabetes.

[439]  J. Wegiel,et al.  Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice , 2004, Brain Research.

[440]  C. Langefeld,et al.  A genome scan for diabetic nephropathy in African Americans. , 2004, Kidney international.

[441]  F. Marceau,et al.  Bradykinin receptor ligands: therapeutic perspectives , 2004, Nature Reviews Drug Discovery.

[442]  J. Clària,et al.  F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. , 2004, Metabolism: clinical and experimental.

[443]  N. Joan Abbott,et al.  Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology , 2004, Neurochemistry International.

[444]  Rhoda Au,et al.  Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.

[445]  H. Haller,et al.  Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. , 2004, Diabetes.

[446]  A. Vinik,et al.  Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. , 2004, Diabetes care.

[447]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[448]  A. Vinik,et al.  Diabetic neuropathies. , 2004, The Medical clinics of North America.

[449]  R. Klein,et al.  Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.

[450]  A. Vinik,et al.  Focal entrapment neuropathies in diabetes. , 2004, Diabetes care.

[451]  J. Arezzo,et al.  Diabetic somatic neuropathies. , 2004, Diabetes care.

[452]  Wadih Arap,et al.  Reversal of obesity by targeted ablation of adipose tissue , 2004, Nature Medicine.

[453]  C. Stehouwer,et al.  Impaired Microvascular Function in Obesity: Implications for Obesity-Associated Microangiopathy, Hypertension, and Insulin Resistance , 2004, Circulation.

[454]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[455]  C. Langefeld,et al.  Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[456]  P. Abraham,et al.  Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes. , 2004, Diabetes.

[457]  O. Raitakari,et al.  Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes , 2004, Heart.

[458]  B. Lévy,et al.  Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. , 2004, The American journal of pathology.

[459]  Mark E. Williams,et al.  Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy , 2004, American Journal of Nephrology.

[460]  P. Low,et al.  Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[461]  A. Krolewski,et al.  Familial factors determine the development of diabetic nephropathy in patients with IDDM , 1996, Diabetologia.

[462]  N. Harris,et al.  Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis) , 1996, Diabetologia.

[463]  M. Hanefeld,et al.  Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid , 1995, Diabetologia.

[464]  N. Harris,et al.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography , 1993, Diabetologia.

[465]  P. Sönksen,et al.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.

[466]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[467]  C. Kilo,et al.  Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patients , 1985, Diabetologia.

[468]  T. Dornan,et al.  Low density lipoprotein cholesterol: An association with the severity of diabetic retinopathy , 1982, Diabetologia.

[469]  C. Langefeld,et al.  Pathogenesis and Treatment of Kidney Disease and Hypertension Heritability of GFR and Albuminuria in Caucasians With Type 2 Diabetes Mellitus , 2004 .

[470]  F. Karpe,et al.  Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. , 2004, Circulation.

[471]  A. Rosenbloom,et al.  Limited joint mobility and diabetic retinopathy demonstrated by fluorescein angiography , 2004, European Journal of Pediatrics.

[472]  Frank J T Staal,et al.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.

[473]  F. Karpe,et al.  Nitric Oxide and &bgr;-Adrenergic Stimulation Are Major Regulators of Preprandial and Postprandial Subcutaneous Adipose Tissue Blood Flow in Humans , 2003 .

[474]  S. Yagihashi,et al.  Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice , 2003, Journal of neurochemistry.

[475]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[476]  A. Vinik,et al.  Nerve Growth Factor and Diabetic Neuropathy , 2003, Experimental diabesity research.

[477]  R. Couture,et al.  Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin‐diabetic rat , 2003, British journal of pharmacology.

[478]  K. Tuttle,et al.  A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[479]  M. Cotter,et al.  Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. , 2003, Life sciences.

[480]  Alan W. Stitt,et al.  The role of advanced glycation in the pathogenesis of diabetic retinopathy. , 2003, Experimental and molecular pathology.

[481]  R. Babaei-Jadidi,et al.  Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. , 2003, Diabetes.

[482]  A. Demaine,et al.  Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications. , 2003, Current medicinal chemistry.

[483]  E. Barrett,et al.  Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. , 2003, American journal of physiology. Endocrinology and metabolism.

[484]  L. Cantley,et al.  Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. , 2003, The Journal of clinical investigation.

[485]  Andrzej S Krolewski,et al.  Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.

[486]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[487]  Craig S. Wong,et al.  Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project. , 2003, Journal of the American Society of Nephrology : JASN.

[488]  Winfried Brenner,et al.  Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.

[489]  J. Haigh,et al.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.

[490]  G. King,et al.  Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. , 2003, Diabetes.

[491]  P. O'Brien,et al.  The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid , 2003 .

[492]  A. Newton,et al.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. , 2003, The Biochemical journal.

[493]  C. Sumner,et al.  The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.

[494]  K. Yoshioka,et al.  Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus , 2003, Diabetes, obesity & metabolism.

[495]  Karen J. Ferguson,et al.  Willis on narcolepsy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[496]  I. Deary,et al.  Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. , 2003, Diabetes.

[497]  Rury R Holman,et al.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). , 2003, Kidney international.

[498]  A. Demaine,et al.  Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. , 2003, Journal of diabetes and its complications.

[499]  P. O'Brien,et al.  The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. , 2003, Diabetes care.

[500]  D. Brutsaert,et al.  Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. , 2003, Physiological reviews.

[501]  H. Hammes,et al.  Pericytes and the Pathogenesis of Diabetic Retinopathy , 2005, Diabetes.

[502]  R. Hanson,et al.  Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. , 2002, Kidney international.

[503]  S. Yusuf,et al.  Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.

[504]  W. Markesbery,et al.  Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants , 2002, Annals of the New York Academy of Sciences.

[505]  J. Provenzale,et al.  Tensor diffusion imaging in B12 leukoencephalopathy. , 2002, Journal of computer assisted tomography.

[506]  A. Boulton,et al.  The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[507]  P. Dandona Endothelium, inflammation, and diabetes , 2002, Current diabetes reports.

[508]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[509]  S. Kaul,et al.  Mechanism of Inducible Regional Dysfunction During Dipyridamole Stress , 2002, Circulation.

[510]  O. Raitakari,et al.  Obesity affects myocardial vasoreactivity and coronary flow response to insulin. , 2002, Obesity research.

[511]  M. Cotter,et al.  Effects of protein kinase Cβ inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism , 2002, Diabetes/metabolism research and reviews.

[512]  F. Port,et al.  Risk factors for proteinuria in a large, multiracial, southeast Asian population. , 2002, Journal of the American Society of Nephrology : JASN.

[513]  T. Bek,et al.  Bradykinin relaxation in small porcine retinal arterioles. , 2002, Investigative ophthalmology & visual science.

[514]  T. Yoshikawa,et al.  Intercellular adhesion molecule‐1 (ICAM‐1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[515]  W. Bradley,et al.  Demyelinating neuropathy in diabetes mellitus. , 2002, Archives of neurology.

[516]  P. Iozzo,et al.  Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. , 2002, American journal of physiology. Endocrinology and metabolism.

[517]  O. Raitakari,et al.  The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes , 2002, Diabetologia.

[518]  I. Komuro,et al.  Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.

[519]  A. Windebank,et al.  Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment , 2002, Muscle & nerve.

[520]  O. Raitakari,et al.  Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. , 2002, Diabetes.

[521]  G. Slama,et al.  eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[522]  K. Donaghue,et al.  Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[523]  B. Perkins,et al.  Carpal tunnel syndrome in patients with diabetic polyneuropathy. , 2002, Diabetes care.

[524]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[525]  C. Kim,et al.  Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. , 2002, Diabetes.

[526]  L. Aiello,et al.  Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[527]  A. Panduro,et al.  The e4 allele of apolipoprotein E gene is a potential risk factor for the severity of macular edema in type 2 diabetic Mexican patients , 2002, Ophthalmic genetics.

[528]  J. Eichberg Protein kinase C changes in diabetes: is the concept relevant to neuropathy? , 2002, International review of neurobiology.

[529]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[530]  S. Kaul,et al.  Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. , 2001, Diabetes.

[531]  S. Kaul,et al.  Decrease in Coronary Blood Flow Reserve During Hyperlipidemia Is Secondary to an Increase in Blood Viscosity , 2001, Circulation.

[532]  S. Tesfaye,et al.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.

[533]  R. Kikkawa,et al.  Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. , 2001, Diabetes care.

[534]  J. Goldstein,et al.  The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy , 2001, Muscle & nerve.

[535]  M. Bromberg,et al.  Painful sensory polyneuropathy associated with impaired glucose tolerance , 2001, Muscle & nerve.

[536]  J. Tang,et al.  Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. , 2001, Diabetes.

[537]  M. Bromberg,et al.  Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. , 2001, Diabetes care.

[538]  R. Castellani,et al.  Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine , 2001 .

[539]  S. Takasawa,et al.  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. , 2001, The Journal of clinical investigation.

[540]  J. Mužík,et al.  Duration of Non-Insulin-Dependent Diabetes mellitus and the TNF-β NcoI Genotype as Predictive Factors in Proliferative Diabetic Retinopathy , 2001, Ophthalmologica.

[541]  D. Alkon,et al.  Role of insulin and insulin receptor in learning and memory , 2001, Molecular and Cellular Endocrinology.

[542]  A. Nitenberg,et al.  Impairment of coronary microvascular dilation in response to cold pressor--induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. , 2001, Diabetes.

[543]  I. Idris,et al.  Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes , 2001, Diabetologia.

[544]  J. Concato,et al.  Effect of Non–Insulin-Dependent Diabetes Mellitus on Myocardial Insulin Responsiveness in Patients With Ischemic Heart Disease , 2001, Circulation.

[545]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[546]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[547]  A Hofman,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[548]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[549]  M. Smith,et al.  Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. , 2001, Free radical biology & medicine.

[550]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[551]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[552]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[553]  S. Woods,et al.  Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. , 2000, Diabetes.

[554]  Sookja K. Chung,et al.  Aldose reductase-deficient mice are protected from reduction of nerve conduction associated with diabetes , 2000 .

[555]  V. Mohan,et al.  Familial clustering of diabetic retinopathy in type 2 diabetic patients , 2000 .

[556]  M. Reljanović,et al.  One Year Follow‐Up In Diabetic Patients After Surgical Treatment Of Carpal Tunnel Syndrome , 2000 .

[557]  Ž. Metelko,et al.  One year follow up in diabetic patients after surgical treatment of carpal tunnel syndrome , 2000 .

[558]  T. Nishikawa,et al.  The missing link: a single unifying mechanism for diabetic complications. , 2000, Kidney international. Supplement.

[559]  K. Sharma,et al.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[560]  R. Hanson,et al.  Segregation analysis of diabetic nephropathy in Pima Indians. , 2000, Diabetes.

[561]  Shao-Ling Zhang,et al.  Molecular mechanism(s) of insulin action on the expression of the angiotensinogen gene in kidney proximal tubular cells , 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[562]  J. Knuuti,et al.  Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. , 2000, The Journal of clinical endocrinology and metabolism.

[563]  T. Saruta,et al.  Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. , 2000, Blood.

[564]  T. Elhadd,et al.  Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. , 2000, Diabetes care.

[565]  A. Zeiher,et al.  Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[566]  S. Rich,et al.  Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. , 2000, Kidney international.

[567]  T. Saruta,et al.  Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. , 2000, Blood.

[568]  H. Tritschler,et al.  Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[569]  S. Kaul,et al.  Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. , 1999, The American journal of physiology.

[570]  R. Klein,et al.  Association of ocular disease and mortality in a diabetic population. , 1999, Archives of ophthalmology.

[571]  N. Hotta,et al.  A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. , 1999, Diabetes.

[572]  L. Groop,et al.  Heritability of albumin excretion rate in families of patients with Type II diabetes , 1999, Diabetologia.

[573]  T. Kigoshi,et al.  Mitochondrial DNA mutations are associated with both decreased insulin secretion and advanced microvascular complications in Japanese diabetic subjects. , 1999, Journal of diabetes and its complications.

[574]  A. Vinik Diabetic neuropathy: pathogenesis and therapy. , 1999, The American journal of medicine.

[575]  M. B. Brown,et al.  Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy , 1999, Neurology.

[576]  J. Gross,et al.  Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.

[577]  Ambady Ramachandran,et al.  Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India. , 1999, Diabetes research and clinical practice.

[578]  E. Barrett,et al.  Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. , 1999, Diabetes.

[579]  J. Isner,et al.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.

[580]  C. Baratti,et al.  Effects of Posttraining Administration of Insulin on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism , 1999, Neurobiology of Learning and Memory.

[581]  E. Friedman Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. , 1999, Diabetes care.

[582]  E. Boyko,et al.  Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. , 1999, Diabetes care.

[583]  P. Parfrey,et al.  Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[584]  N. B. Tütüncü,et al.  Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. , 1998, Diabetes care.

[585]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[586]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[587]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[588]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[589]  A R Jayaweera,et al.  Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? , 1998, Journal of the American College of Cardiology.

[590]  P. Whelton,et al.  Familial aggregation of renal disease in a population-based case-control study. , 1998, Journal of the American Society of Nephrology : JASN.

[591]  F. Gries,et al.  Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[592]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[593]  David G Armstrong,et al.  Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation , 1998, Diabetes Care.

[594]  R. Hanson,et al.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.

[595]  C. Whiteside,et al.  Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. , 1998, Diabetes.

[596]  T. Forst,et al.  Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation. , 1998, Clinical science.

[597]  S. Kudoh,et al.  Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways , 1998 .

[598]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[599]  J. Grande,et al.  Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. , 1998, Kidney international.

[600]  T. Lehtimäki,et al.  Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.

[601]  A. Sjølie,et al.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.

[602]  A. Veves,et al.  The role of endothelial function on the foot. Microcirculation and wound healing in patients with diabetes. , 1998, Clinics in podiatric medicine and surgery.

[603]  R. Danis,et al.  Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. , 1998, Investigative ophthalmology & visual science.

[604]  L. Martens,et al.  Costs and duration of care for lower extremity ulcers in patients with diabetes. , 1998, Clinical therapeutics.

[605]  W. Banks,et al.  Effect of Diabetes Mellitus on the Permeability of the Blood–Brain Barrier to Insulin , 1997, Peptides.

[606]  S. Bursell,et al.  Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. , 1997, Investigative ophthalmology & visual science.

[607]  M. Omata,et al.  Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Cardiology.

[608]  A. Zacharias,et al.  Autoimmune diabetic neuropathy. , 1997, Neurologic clinics.

[609]  S. Kaul,et al.  Recent advances in myocardial contrast echocardiography. , 1997, Current opinion in cardiology.

[610]  Y Nishizuka,et al.  Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[611]  E. Barrett,et al.  Hemodynamic Actions of Insulin in Rat Skeletal Muscle: Evidence for Capillary Recruitment , 1997, Diabetes.

[612]  R. Dietz,et al.  High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. , 1997, Circulation research.

[613]  P. Thomas,et al.  Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.

[614]  W. Motz,et al.  Impaired Coronary Flow Reserve in NIDDM: A Possible Role for Diabetic Cardiopathy in Humans , 1997, Diabetes.

[615]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[616]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[617]  H. Hammes,et al.  Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.

[618]  S. Kaul,et al.  Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.

[619]  C H Chang,et al.  Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. , 1997, Microvascular research.

[620]  M. Ward,et al.  Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[621]  A. Signorile,et al.  Oxidative protein damage in human diabetic eye: evidence of a retinal participation , 1997, European journal of clinical investigation.

[622]  K. Federlin,et al.  A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[623]  J. Samra,et al.  Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. , 1996, Clinical science.

[624]  青木 琢也 肺動脈血管内皮細胞における高濃度酸素暴露による intercellular adhesion molecule-1 (ICAM-1)発現と抗酸化機構との関連 , 1996 .

[625]  H. Vlassara Advanced glycation end-products and atherosclerosis. , 1996, Annals of medicine.

[626]  S. Bursell,et al.  Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. , 1996, Science.

[627]  M. Faul,et al.  (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. , 1996, Journal of medicinal chemistry.

[628]  R. Bucala,et al.  Recent Progress in Advanced Glycation and Diabetic Vascular Disease: Role of Advanced Glycation End Product Receptors , 1996, Diabetes.

[629]  A. Vinik,et al.  The Natural Progression of Autonomic Neuropathy and Autonomic Function Tests in a Cohort of People With IDDM , 1996, Diabetes Care.

[630]  S. Chokroverty,et al.  Diabetic Amyotrophy: Current Concepts , 1996, Seminars in neurology.

[631]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[632]  C. Baratti,et al.  Effects of Posttraining Administration of Glucose on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism , 1996, Neurobiology of Learning and Memory.

[633]  E. Hirasaki,et al.  Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats. , 1996, European journal of endocrinology.

[634]  R. Busse,et al.  Molecular Responses of Endothelial Tissue to Kinins , 1996, Diabetes.

[635]  P. Bennett,et al.  Kidney Diseases in Diabetes , 1996 .

[636]  T. Miyata,et al.  Advanced glycation end-products in diabetic nephropathy. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[637]  M. Hanefeld,et al.  Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). , 1995, Diabetologia.

[638]  D. A. Krendel,et al.  Successful treatment of neuropathies in patients with diabetes mellitus. , 1995, Archives of neurology.

[639]  K. Kamata,et al.  Decreased Ca2+ influx into the endothelium contributes to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic mice. , 1995, Research communications in molecular pathology and pharmacology.

[640]  M. Edmonds Diabetes: Clinical Science in Practice , 1995 .

[641]  E Mervaala,et al.  Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[642]  T. Batchelder,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1995, Archives of ophthalmology.

[643]  K. Borch-Johnsen,et al.  Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. , 1995, Clinical science.

[644]  B. Freedman,et al.  Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[645]  D. Robbins,et al.  Diabetes : clinical science in practice , 1995 .

[646]  P. Corr,et al.  Neural Dysfunction and Metabolic Imbalances in Diabetic Rats: Prevention by Acetyl-L-Carnitine , 1994, Diabetes.

[647]  G S Kassab,et al.  Morphometry of pig coronary venous system. , 1994, The American journal of physiology.

[648]  H. Freyberger,et al.  [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent]. , 1994, Medizinische Klinik.

[649]  M B Brown,et al.  A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.

[650]  L. Kappos,et al.  Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[651]  A. Schmidt,et al.  Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[652]  P. Cavanagh,et al.  Assessment and management of foot disease in patients with diabetes. , 1994, The New England journal of medicine.

[653]  G. King,et al.  Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.

[654]  N. Fineberg,et al.  Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. , 1994, The Journal of clinical investigation.

[655]  E. Feldman,et al.  The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. , 1994, The Journal of clinical investigation.

[656]  S. Kagami,et al.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. , 1994, The Journal of clinical investigation.

[657]  C. Lacroix,et al.  Nerve biopsy findings in different patterns of proximal diabetic neuropathy , 1994, Annals of neurology.

[658]  P. Björntorp,et al.  Muscle Fiber Composition and Capillary Density in Women and Men With NIDDM , 1994, Diabetes Care.

[659]  G. Ferrari,et al.  α, βI, βII, δ, and ε Protein Kinase C Isoforms and Compound Activity in the Sciatic Nerve of Normal and Diabetic Rats , 1994 .

[660]  G. Ferrari,et al.  Alpha, beta I, beta II, delta, and epsilon protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. , 1994, Journal of neurochemistry.

[661]  R. Klein,et al.  Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. , 1994, Archives of ophthalmology.

[662]  R. Bucala,et al.  Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. , 1993, The American journal of pathology.

[663]  W. Rathmann,et al.  Mortality in Diabetic Patients with Cardiovascular Autonomic Neuropathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[664]  S. Bursell,et al.  Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.

[665]  C Cobelli,et al.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.

[666]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[667]  A. Neil,et al.  A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDM , 1993, Diabetes Care.

[668]  A. Nitenberg,et al.  Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function , 1993, Diabetes.

[669]  P. Watkins,et al.  Progression of Diabetic Autonomic Neuropathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[670]  T. Lyons,et al.  Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[671]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[672]  M. Mcdaniel,et al.  Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.

[673]  P. Scheltens,et al.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.

[674]  D. Dorsa,et al.  Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus , 1993, Brain Research.

[675]  D. Hewett‐Emmett,et al.  Mortality of Mexican Americans With NIDDM: Retinopathy and other predictors in Starr County, Texas , 1993, Diabetes Care.

[676]  L. Melton,et al.  Erratum: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study (Neurology (1993) 43 (817-824)) , 1993 .

[677]  Barbara E K Klein,et al.  Epidemiology of Proliferative Diabetic Retinopathy , 1992, Diabetes Care.

[678]  G. King,et al.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[679]  M. Laakso,et al.  Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM , 1992, Diabetes.

[680]  E. Tsilibary,et al.  Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. , 1992, The Journal of biological chemistry.

[681]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[682]  S. Britland,et al.  Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology , 1992, Pain.

[683]  M. Loeken,et al.  Stimulation of endothelin-1 gene expression by insulin in endothelial cells. , 1991, The Journal of biological chemistry.

[684]  B. Agranoff,et al.  Diminished Specific Activity of Cytosolic Protein Kinase C In Sciatic Nerve of Streptozocin-Induced Diabetic Rats and Its Correction by Dietary myo-Inositol , 1991, Diabetes.

[685]  D. Troyer,et al.  High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. , 1991, The American journal of physiology.

[686]  L. Yannuzzi,et al.  The effects of lipid lowering on diabetic retinopathy. , 1991, American journal of ophthalmology.

[687]  M. Laakso,et al.  Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. , 1991, The Journal of clinical endocrinology and metabolism.

[688]  L. Melton,et al.  The Rochester Diabetic Neuropathy Study , 1991, Neurology.

[689]  J. Pickup,et al.  Textbook of Diabetes , 1991 .

[690]  R. Frank,et al.  On the pathogenesis of diabetic retinopathy. A 1990 update. , 1991, Ophthalmology.

[691]  J. V. van Swieten,et al.  Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. , 1991, Brain : a journal of neurology.

[692]  D. Armstrong,et al.  Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. , 1991, Free radical biology & medicine.

[693]  Z. Katušić,et al.  Superoxide anion and endothelial regulation of arterial tone. , 1991, Seminars in perinatology.

[694]  E. Bouskela,et al.  Nailfold capillaroscopy in non-insulin dependent diabetes mellitus: blood flow velocity during rest and post-occlusive reactive hyperaemia. , 1990, Clinical physiology.

[695]  T. Takasu,et al.  Characteristics of cranial nerve palsies in diabetic patients. , 1990, Diabetes research and clinical practice.

[696]  C. Davidson,et al.  Increase in Diacylglycerol Mass in Isolated Glomeruli by Glucose From De Novo Synthesis of Glycerolipids , 1990, Diabetes.

[697]  M. Laakso,et al.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. , 1990, The Journal of clinical investigation.

[698]  D. DeMets,et al.  Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? , 1989, Archives of internal medicine.

[699]  R. Engerman,et al.  Pathogenesis of Diabetic Retinopathy , 1989, Diabetes.

[700]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[701]  D L DeMets,et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.

[702]  D. Mouton,et al.  Prevalence of diabetic retinopathy and evaluation of risk factors. A review of 1,005 diabetic clinic patients. , 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[703]  C. Kilo,et al.  Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. , 1988, Diabetes/metabolism reviews.

[704]  S. Woods,et al.  Insulin in the brain. , 1987, Annual review of physiology.

[705]  P. Marchetti,et al.  Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. , 1987, Ophthalmic research.

[706]  M. Marcus,et al.  Microvascular distribution of coronary vascular resistance in beating left ventricle. , 1986, The American journal of physiology.

[707]  G. Bresnick Diabetic retinopathy viewed as a neurosensory disorder. , 1986, Archives of ophthalmology.

[708]  P. Dyck,et al.  Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy , 1986, Annals of neurology.

[709]  I. Herman,et al.  Microvascular pericytes contain muscle and nonmuscle actins , 1985, The Journal of cell biology.

[710]  J. Tooke,et al.  Skin microvascular autoregulatory responses in type I diabetes: the influence of duration and control. , 1985, International journal of microcirculation, clinical and experimental.

[711]  A. Cerami,et al.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.

[712]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[713]  R. E. Anderson,et al.  Lipid peroxidation and retinal degeneration. , 1984, Current eye research.

[714]  N. Maclaren,et al.  Limited Joint Mobility in Childhood Diabetes: Family Studies , 1983, Diabetes Care.

[715]  J. Miller,et al.  Muscle Capillary Basement Membrane Width and Its Relationship to Diabetes Mellitus in Monozygotic Twins , 1983, Diabetes.

[716]  G. Blankenship,et al.  Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. , 1981, Ophthalmology.

[717]  C. Kilo,et al.  Pericyte Degeneration and Basement Membrane Thickening in Skeletal Muscle Capillaries of Human Diabetics , 1981, Diabetes.

[718]  V. Fischer,et al.  Capillary Basal Laminar Thickness in Diabetic Human Myocardium , 1979, Diabetes.

[719]  M. Davis,et al.  Prognosis for life in patients with diabetes: relation to severity of retinopathy. , 1979, Transactions of the American Ophthalmological Society.

[720]  P. Hoffman,et al.  Influence of Fixation and Morphometric Technics on Capillary Basement-membrane Thickening Prevalence Data in Diabetes , 1976, Diabetes.

[721]  H. Parving,et al.  Increased metabolic turnover rate and transcapillary escape rate of albumin in long-term juvenile diabetics. , 1975, Scandinavian journal of clinical and laboratory investigation.

[722]  K. Lipscomb,et al.  Effects of coronary stenoses on coronary flow reserve and resistance. , 1974, The American journal of cardiology.

[723]  R. Unger,et al.  Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.

[724]  P. Johnson,et al.  Autoregulation of Blood Flow , 1963, Science.